Fundraising Fox
/Companies
Sign in

Ivantis Inc

Acquired

Irvine, US · 5 known investors

Find your way into Ivantis Inc

Sign up to find every way you can get introduced to Ivantis Inc

  • Your email: who you already know at Ivantis Inc, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ivantis Inc team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Acquired by Alcon January 2022 · $479M ($479 million upfront, plus potential development and commercial milestone payments) · source ↗

Ivantis was a medical device company founded in 2007 in Irvine, California, that developed the Hydrus Microstent, a minimally invasive device for treating glaucoma during cataract surgery.

Founders & leadership

DVDavid Van Meter
David Van MeterExecutive
BF
Bruce FeuchterNamed on SEC filing

Board

TB
Tara ButlerBoard directorManaging Director at Ascension Ventures
DR
Douglas RoederBoard director
ABAli Behbahani
Ali BehbahaniBoard directorPartner, Co-Head of Healthcare at New Enterprise Associates (NEA)
RA
Randy AlexanderBoard director
TY
Thong Yuen PoonBoard director
AG
Albert GrafBoard director
BGBen Gust
Ben GustDirector2014–2022Managing Partner at Virescent Ventures

Investors · 5

Foresite Capitallisted by Foresite CapitalWest Hollywood

How we know: Foresite Capital's portfolio page · funding news · Not right? Tell us

RA Capitallisted by RA CapitalBoston

How we know: RA Capital's portfolio page · funding news · Not right? Tell us

MemorialCare Innovation FundreportedLong Beach

How we know: funding news · Not right? Tell us

New Enterprise Associates (NEA)reportedMenlo Park · $200K – $40Mvia Ali Behbahani · board

How we know: board seat on SEC Form D · funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$83.9M disclosed across 2 rounds · 2014–2017

▶$25MraisedJan 2017 · 12 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • David Van MeterExecutive Officer, Director
  • Randy AlexanderDirector
  • Ben GustDirector
  • Douglas RoederDirector
  • Ali BehbahaniDirector
  • Christopher ShenDirector
  • Tara ButlerDirector
  • Albert GrafDirector
  • Bruce FeuchterExecutive Officer
Offering amount
$25M
Amount sold
$25M
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$58.9MraisedOct 2014 · 14 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tara ButlerDirector
  • Douglas RoederDirector
  • Ali BehbahaniDirector
  • Randy AlexanderDirector
  • Thong Yuen PoonDirector
  • Albert GrafDirector
  • Bruce FeuchterExecutive Officer
  • David Van MeterExecutive Officer, Director
  • Ben GustDirector
Offering amount
$71.4M
Amount sold
$58.9M
First sale
Sep 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Ivantis Recognized For Innovation, Excellence And Company Cultureprnewswire.com · Dec 2020Ivantis Raises $25 Million Series C to Fund Future US Commercialization of the Hydrus(TM) Microstent for Minimally Invasive Glaucoma Surgery (MIGS)globenewswire.com · Jan 2017

Frequently asked questions

What does Ivantis Inc do?
Ivantis was a medical device company founded in 2007 in Irvine, California, that developed the Hydrus Microstent, a minimally invasive device for treating glaucoma during cataract surgery.
Who are Ivantis Inc's investors?
Ivantis Inc's investors include Ascension Ventures, Foresite Capital, RA Capital, MemorialCare Innovation Fund, New Enterprise Associates (NEA).
How much funding has Ivantis Inc raised?
Ivantis Inc has disclosed $83.9M raised across 2 rounds.
Where is Ivantis Inc headquartered?
Ivantis Inc is headquartered in Irvine, US.